What is Castle Biosciences's contingent liabilities?

Castle Biosciences (CSTL) reported contingent liabilities of $1M in Q1 2026.

What does contingent liabilities mean?

This represents the total estimated fair value of obligations to pay additional consideration to sellers following an asset acquisition, contingent upon the achievement of specific future performance milestones or financial targets. It reflects the potential future cash outflows tied to the integration and success of acquired technologies or business units. Investors monitor this to assess the company's commitment to inorganic growth and the potential impact of earn-out provisions on future liquidity.

Castle Biosciences CSTL Contingent liabilities

Contingent liabilities at other companies

Rigel PharmaceuticalsRIGL

$5M—

Castle BiosciencesCSTL

$1M—

Alarm.com HoldingsALRM

$305.75K-43.6%

Central Garden & Pet CompanyCENT

$500K+10,100%

Covenant Logistics GroupCVLG

-$208.75K-4.4%

FlowserveFLS

$168.5K-95.5%

Other financials

Income statement

See full

Revenue$83.7M-4.9%

Gross profit$63.1M-11.8%

Operating income-$18.4M+34.1%

Net income-$14.5M+43.8%

EPS (diluted)-$0.49+45.6%

Balance sheet

See full

Cash & equivalents$63.8M-28.9%

Total debt$36.7M+42.1%

Total equity$461.4M+4.8%

Total assets$547.8M+9.2%

Cash flow

See full

Operating cash flow-$22.1M-267%

CapEx$12.5M+163%

Free cash flow-$34.6M-221%

Valuation

See full

Market cap$694.86M+29.9%

Enterprise value$667.82M+41.8%

P/S2×+0.5×

Profitability

See full

Gross margin77.9%-4.1pp

Operating margin-9.8%-30.8pp

Net margin-3.8%-10.2pp

FCF margin1.3%-10.7pp

Returns & leverage

See full

Return on equity-2.8%-10.6pp

Debt / equity0.1×0.0×

Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's contingent liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Castle Biosciences's contingent liabilities?: Castle Biosciences (CSTL) reported contingent liabilities of $1M in Q1 2026.
What does contingent liabilities mean?: This represents the total estimated fair value of obligations to pay additional consideration to sellers following an asset acquisition, contingent upon the achievement of specific future performance milestones or financial targets. It reflects the potential future cash outflows tied to the integration and success of acquired technologies or business units. Investors monitor this to assess the company's commitment to inorganic growth and the potential impact of earn-out provisions on future liquidity.